316 related articles for article (PubMed ID: 2234402)
1. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.
McDonald JW; Silverstein FS; Cardona D; Hudson C; Chen R; Johnston MV
Neuroscience; 1990; 36(3):589-99. PubMed ID: 2234402
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model.
McDonald JW; Silverstein FS; Johnston MV
Brain Res; 1989 Jun; 490(1):33-40. PubMed ID: 2667694
[TBL] [Abstract][Full Text] [Related]
3. MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats.
McDonald JW; Silverstein FS; Johnston MV
Neuroscience; 1990; 38(1):103-13. PubMed ID: 2255390
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
5. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats.
Barks JD; Liu XH; Sun R; Silverstein FS
Neuroscience; 1997 Jan; 76(2):397-409. PubMed ID: 9015325
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development.
McDonald JW; Trescher WH; Johnston MV
Brain Res; 1992 Jun; 583(1-2):54-70. PubMed ID: 1380402
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
Foster AC; Gill R; Woodruff GN
J Neurosci; 1988 Dec; 8(12):4745-54. PubMed ID: 2904493
[TBL] [Abstract][Full Text] [Related]
8. Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801.
Gass P; Herdegen T; Bravo R; Kiessling M
Neuroscience; 1993 Apr; 53(3):749-58. PubMed ID: 8487953
[TBL] [Abstract][Full Text] [Related]
9. Stimulation and inhibition of N-methyl-D-aspartate receptors in rats: developing a seizure model.
Hallak M; Irtenkauf SM; Janusz CA; Cotton DB
Am J Obstet Gynecol; 1993 Sep; 169(3):695-700. PubMed ID: 8372882
[TBL] [Abstract][Full Text] [Related]
10. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology.
van Lookeren Campagne M; Verheul JB; Nicolay K; Balázs R
J Cereb Blood Flow Metab; 1994 Nov; 14(6):1011-23. PubMed ID: 7929643
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate-mediated injury enhances quisqualic acid-stimulated phosphoinositide turnover in perinatal rats.
Chen CK; Silverstein FS; Johnston MV
J Neurochem; 1992 Sep; 59(3):963-71. PubMed ID: 1322976
[TBL] [Abstract][Full Text] [Related]
12. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats.
Wang P; Barks JD; Silverstein FS
Neuroscience; 1999 Jan; 88(2):585-97. PubMed ID: 10197777
[TBL] [Abstract][Full Text] [Related]
13. CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo.
Schoepp DD; Salhoff CR; Hillman CC; Ornstein PL
J Neural Transm Gen Sect; 1989; 78(3):183-93. PubMed ID: 2553073
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats.
Hagan P; Barks JD; Yabut M; Davidson BL; Roessler B; Silverstein FS
Neuroscience; 1996 Dec; 75(4):1033-45. PubMed ID: 8938739
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate, kainate and quisqualate release endogenous adenosine from rat cortical slices.
Hoehn K; White TD
Neuroscience; 1990; 39(2):441-50. PubMed ID: 1982346
[TBL] [Abstract][Full Text] [Related]
16. In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists.
Santiago M; Venero JL; Machado A; Cano J
Brain Res; 1992 Jul; 586(2):203-7. PubMed ID: 1521154
[TBL] [Abstract][Full Text] [Related]
17. Activation of NMDA receptors protects against glutamate neurotoxicity in the retina: evidence for the involvement of neurotrophins.
Rocha M; Martins RA; Linden R
Brain Res; 1999 May; 827(1-2):79-92. PubMed ID: 10320696
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
Lees GJ; Leong W
Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
[TBL] [Abstract][Full Text] [Related]
19. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats.
Buchan A; Li H; Pulsinelli WA
J Neurosci; 1991 Apr; 11(4):1049-56. PubMed ID: 2010804
[TBL] [Abstract][Full Text] [Related]
20. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
Criswell HE; Johnson KB; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
